Zobrazeno 1 - 10
of 645
pro vyhledávání: '"CCDC170"'
Autor:
Zhang, Jiaqiang1 (AUTHOR), Cai, Qinlei2 (AUTHOR), Chen, Wangxue1 (AUTHOR), Huang, Maoxue1 (AUTHOR), Guan, Renyang1 (AUTHOR), Jin, Tianbo3,4 (AUTHOR) jintianbo@gmail.com
Publikováno v:
Scientific Reports. 4/12/2022, Vol. 12 Issue 1, p1-9. 9p.
Publikováno v:
Biology Open, Vol 10, Iss 4 (2021)
MicroRNAs (miRNAs) play essential roles in regulating bone formation and homeostasis. Genomic variations within miRNA target sites may therefore be important sources of genetic differences in osteoporosis risk. The function of CCDC170 in bone biology
Externí odkaz:
https://doaj.org/article/8ede736e39474228b40b2fb2a1102062
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Osteoporosis (OP) has plagued many women for years, and bone density loss is an indicator of OP. The purpose of this study was to evaluate the relationship between the polymorphism of the rs7586085, CCDC170 and GALNT3 gene polymorphisms and
Externí odkaz:
https://doaj.org/article/9b328c42435a4d67933c670b769baf1e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Li, Jianxiong1 (AUTHOR), Liang, Huaguo2 (AUTHOR), Xiao, Wentao1 (AUTHOR), Wei, Peng2 (AUTHOR), Chen, Hongmei2 (AUTHOR), Chen, Zexin2 (AUTHOR), Yang, Ruihui2 (AUTHOR), Jiang, Huan1 (AUTHOR) YuanaJiang@163.com, Zhang, Yongli2 (AUTHOR) zyl28_gdpu@163.com
Publikováno v:
BMC Cancer. 4/6/2023, Vol. 23 Issue 1, p1-13. 13p.
Autor:
Hong Zheng, Hongwei Han, Wei Wang, Lina Zhang, Yanrui Zhao, Ben Liu, Qiong Wang, Kexin Chen, Qinghua Wang
Publikováno v:
Aging (Albany NY)
Genome-wide association studies have revealed that multiple single-nucleotide polymorphisms in the intergenic region between estrogen receptor 1 and coiled-coil domain containing 170 (CCDC170) are associated with breast cancer risk. We performed micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::071b16ede433bd8292c78f404c6f5c28
https://doi.org/10.18632/aging.202315
https://doi.org/10.18632/aging.202315
Autor:
Pengtao Jiang, Yueran Li, Andrey Poleshko, Valentina Medvedeva, Natalia Baulina, Yongchao Zhang, Yan Zhou, Carolyn M. Slater, Trinity Pellegrin, Jason Wasserman, Michael Lindy, Andrey Efimov, Mary Daly, Richard A. Katz, Xiaowei Chen
Publikováno v:
EBioMedicine, Vol 22, Iss C, Pp 28-43 (2017)
Genome-Wide Association Studies (GWAS) and subsequent fine-mapping studies (>50) have implicated single nucleotide polymorphisms (SNPs) located at the CCDC170/C6ORF97-ESR1 locus (6q25.1) as being associated with the risk of breast cancer. Surprisingl
Externí odkaz:
https://doaj.org/article/b9d1dcb371e84004beb5648fab7f29b8
Autor:
Wang Q; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Zhao Y; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Zheng H; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Wang Q; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Wang W; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Liu B; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Han H; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China., Zhang L; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China.; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China., Chen K; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, P.R. China.; Tianjin’s Clinical Research Center for Cancer, Tianjin 300060, P.R. China.; Key Laboratory of Molecular Cancer Epidemiology, Tianjin 300060, P.R. China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China.
Publikováno v:
Aging [Aging (Albany NY)] 2020 Dec 03; Vol. 13 (1), pp. 1332-1356. Date of Electronic Publication: 2020 Dec 03.